| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,358 | $140.53 | $471,889.28 | - | |
| Feb 25, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 4,036 | $144.91 | $584,847.10 | - | |
| Feb 25, 2019 | WAT Waters Corp /de/ | Berendt Michael J54 | Director | Sell | 3,000 | $239.64 | $718,920.00 | -12.2% | |
| Feb 25, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 4,076 | $145.78 | $594,213.81 | - | |
| Feb 25, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 8,285 | $144.53 | $1,197,432.60 | -0.1% | |
| Feb 25, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 5,002 | $145.40 | $727,274.53 | - | |
| Feb 25, 2019 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 4,210 | $144.55 | $608,574.51 | -0.6% | |
| Feb 25, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 6,295 | $144.32 | $908,496.07 | - | |
| Feb 25, 2019 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 4,000 | $145.43 | $581,710.00 | -0.8% | |
| Feb 25, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 5,966 | $145.20 | $866,247.94 | - | |
| Feb 25, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 7,643 | $144.69 | $1,105,897.34 | -0.1% | |
| Feb 25, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,000 | $146.02 | $438,056.77 | - | |
| Feb 25, 2019 | TMO Thermo Fisher Scientific Inc. | Herrema Gregory J. | Senior Vice President | Sell | 19,808 | $253.29 | $5,017,128.28 | -16.4% | |
| Feb 25, 2019 | EXAS Exact Sciences Corp | Coward D Scott77 | Chief Administrative Officer | Sell | 6,143 | $90.55 | $556,254.79 | -6.7% | |
| Feb 25, 2019 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 4,445 | $90.55 | $402,499.20 | -10.5% | |
| Feb 25, 2019 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 16,400 | $90.55 | $1,485,036.40 | -1.8% | |
| Feb 25, 2019 | MTD Mettler Toledo International Inc/ | Salice Thomas P65 | Director | Sell | 1,300 | $685.50 | $891,150.00 | -1.2% | |
| Feb 25, 2019 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 27,112 | $679.13 | $18,412,520.12 | -2.8% | |
| Feb 22, 2019 | CRL Charles River Laboratories International, Inc. | Milne George M Jr59 | Director | Sell | 4,540 | $143.00 | $649,220.00 | -15.7% | |
| Feb 22, 2019 | CDNA Caredx, Inc. | King Sasha77 | Chief Commercial Officer | Sell | 7,500 | $29.03 | $217,725.00 | -9.2% | |
| Feb 22, 2019 | A Agilent Technologies, Inc. | Doak Mark | Sr. Vice President | Sell | 16,421 | $77.95 | $1,280,016.95 | -12.5% | |
| Feb 22, 2019 | MTD Mettler Toledo International Inc/ | Chu Wah-Hui63 | Director | Sell | 500 | $678.00 | $339,000.00 | -14.9% | |
| Feb 21, 2019 | RVTY Revvity, Inc. | Michas Alexis P68 | Director | Sell | 2,118 | $92.96 | $196,882.93 | -3.5% | |
| Feb 21, 2019 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 35,000 | $672.50 | $23,537,566.93 | -1.9% | |
| Feb 20, 2019 | IQV Iqvia Holdings Inc. | Staub W Richard | See Remarks | Sell | 27,025 | $140.54 | $3,798,185.50 | -38.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.